Compare Lithium Americas Corp (LAC) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lithium Americas Corp vs DENTSPLY SIRONA Inc — how do they compare? Lithium Americas Corp trades at $2.35 (market cap $850.38M), while DENTSPLY SIRONA Inc trades at $8.83 (market cap $1.73B). The key difference: DENTSPLY SIRONA Inc is far larger — about 2× Lithium Americas Corp's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lithium Americas Corp for 27 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| LAC | XRAY | |
|---|---|---|
Market Cap | $850.38M | $1.73B |
Volume | 8,804,637 | 6,198,582 |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $14.68 |
52-Week Low | $2.35 | $8.52 |
Typical Hold Time | 27 Days | 72 Days |
Enterprise Value | $1.19B | $3.80B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lithium Americas (LAC) trades at $2.36, down 2.07% with a bearish technical signal despite bullish oscillators. The company shows negative profitability with ROE at -9.56% and ROA at -3.99%, though it has beaten EPS estimates in recent quarters. Analyst consensus is mixed with 47% buy ratings and a $4.00 price target, representing 69% upside potential. Recent news highlights construction progress at Thacker Pass and a $175 million financing round to strengthen the balance sheet.
LAC presents a high-risk, high-reward opportunity as it transitions from development to execution phase. The stock trades below book value (P/B 0.6) but faces significant execution risks and negative cash flow from operations. Upside depends on successful lithium production ramp-up and favorable lithium pricing, while downside risks include project delays and commodity price volatility.
DENTSPLY SIRONA (XRAY) trades at $8.69, near its 52-week low, with a bearish technical signal from moving averages. The company reported a Q2 2026 earnings beat but faces declining revenue and negative net income margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The outlook remains challenging with persistent profitability issues and high debt levels, though analyst consensus suggests upside potential with a $13 price target. Key risks include margin pressure and competitive threats, requiring careful monitoring of the company's turnaround execution for any recovery signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
